Thrombotic Thrombocytopenic Purpura Presenting as a Complex Migraine: A Case Report
Abstract
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, fever, neurologic symptoms, and renal dysfunction. Neurologic manifestations can range from mild headaches to severe sequelae such as seizures, stroke, and coma. TTP may present atypically, including with symptoms such as complex migraines, which can complicate diagnosis and delay treatment. Early recognition and prompt treatment are essential, as untreated TTP carries a high mortality rate. This case report highlights the importance of considering TTP in the differential diagnosis of patients presenting with a first-time complex migraine, as it can occasionally be the initial manifestation of this rare and serious condition. It also underscores the necessity of performing a complete blood count (CBC) in patients with new neurological symptoms, as complex pathologies like TTP can present with overlapping features. We present the case of a 19-year-old male whose initial complaint of a complex migraine led to the diagnosis and successful treatment of TTP with plasmapheresis, corticosteroids, and rituximab.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.